Use of an employment advisory service by cancer survivors

Journal of Psychosocial Oncology
Emma R Lawlor, Michael Donnelly

Abstract

Employment issues for cancer survivors (CS) were investigated from the perspective of Northern Ireland government general employment advisors. An e-survey was designed and developed based on the results of a scoping search of journal articles, previously validated questionnaires and relevant related surveys; discussions of draft versions of the e-survey and method with lead representatives of stakeholder organizations; and a pilot study with seven prospective respondents. The e-survey and subsequent reminder to employment advisors were distributed internally by the government employment advisory agency. The e-survey was completed by 78/156 (50%) advisors, the majority of whom (74%) received a request for advice in the last year from at least one CS. Most CS used the employment service less than 1 year (52%) or 1 year or more after treatment (32%). Fatigue was the most commonly reported barrier to returning to work (10%) and staying in work (14%), and a supportive employer was the top facilitating factor in returning to (21%) and continuing in (27%), employment. Although most advisors had a positive attitude about a CS's capacity to return to work, half were uncertain about how best to advise cancer survivors.

References

Jan 5, 2002·Seminars in Oncology Nursing·J H RowlandE J Feuer
Mar 29, 2002·Psycho-oncology·Evelien R SpeltenJos H A M Verbeek
Jul 12, 2002·Psycho-oncology·Cathy J Bradley, Heather L Bednarek
Feb 1, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Maria HewittRosemary Yancik
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Taina Taskila-BrandtMarja-Liisa Lindbohm
Feb 9, 2005·Cancer·Pamela Farley ShortKaan Tunceli
Sep 17, 2005·CA: a Cancer Journal for Clinicians·Barbara Hoffman
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reynard R BouknightZhehui Luo
Mar 31, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Saevar B GudbergssonAlv A Dahl
Feb 24, 2007·Journal of Occupational Rehabilitation·Joanna PryceCheryl Haslam
May 15, 2007·Acta Oncologica·T Taskila, M L Lindbohm
May 15, 2007·Acta Oncologica·Patricia A Ganz, Julienne E Bower
Dec 8, 2007·Breast Cancer Research and Treatment·O Minton, P Stone
Mar 18, 2008·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Ziv AmirKaren Luker
Mar 20, 2008·British Journal of Cancer·A G E M de BoerF J H van Dijk
Jul 16, 2008·Psycho-oncology·Dorte M Rasmussen, Beth Elverdam
Aug 1, 2008·Occupational Medicine·R Molina VillaverdeM Gonzalez Baron
Nov 13, 2008·Journal of Occupational Rehabilitation·Elizabeth A GrunfeldAlethea F Cooper
Aug 21, 2009·Occupational Medicine·Z Amir, J Brocky
Sep 22, 2010·Occupational Medicine·E A GrunfeldA F Cooper
Feb 18, 2011·The Cochrane Database of Systematic Reviews·Angela Gem de BoerJos H Verbeek
Mar 17, 2012·Scandinavian Journal of Work, Environment & Health·Anja Mehnert, Uwe Koch

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

RCM Midwives : the Official Journal of the Royal College of Midwives
Breedagh Hughes
© 2021 Meta ULC. All rights reserved